{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:33:56Z","timestamp":1785882836784,"version":"3.56.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ccc.2021.11.010","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:14:33Z","timestamp":1648750473000},"page":"317-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Uncommon Causes of Acute Kidney Injury"],"prefix":"10.1016","volume":"38","author":[{"given":"Cassandra L.","family":"Formeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos L.","family":"Manrique-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10212","key":"10.1016\/j.ccc.2021.11.010_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2021.11.010_bib3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2014070724","article-title":"Classifying AKI by urine output versus serum creatinine level","volume":"26","author":"Kellum","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrneph.2011.13","article-title":"Acute kidney injury: what's the prognosis?","volume":"7","author":"Murugan","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinternmed.2011.1202","article-title":"Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction","volume":"172","author":"Amin","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib6","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1542\/peds.2013-0794","article-title":"Electronic health record identification of nephrotoxin exposure and associated acute kidney injury","volume":"132","author":"Goldstein","year":"2013","journal-title":"Pediatrics"},{"issue":"11 Pt C","key":"10.1016\/j.ccc.2021.11.010_bib7","first-page":"E1027","article-title":"Severe post-renal acute kidney injury, post-obstructive diuresis and renal recovery","volume":"110","author":"Hamdi","year":"2012","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s001340051173","article-title":"Acute renal failure in patients over 80 years old: 25-years' experience","volume":"26","author":"Akposso","year":"2000","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.ackd.2016.03.002","article-title":"Intra-abdominal hypertension and abdominal compartment syndrome: an underappreciated cause of acute kidney injury","volume":"23","author":"Patel","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/CCM.0b013e31817c7a4d","article-title":"Incidence and clinical effects of intra-abdominal hypertension in critically ill patients","volume":"36","author":"Vidal","year":"2008","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.krcp.2016.04.001","article-title":"Risk factors and outcomes of acute renal infarction","volume":"35","author":"Yang","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.ccc.2021.11.010_bib12","doi-asserted-by":"crossref","first-page":"8846622","DOI":"10.1155\/2020\/8846622","article-title":"Acute kidney injury caused by obstructive nephropathy","volume":"2020","author":"Chavez-Iniguez","year":"2020","journal-title":"Int J Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ccell.2012.03.004","article-title":"Intra-abdominal hypertension: evolving concepts","volume":"24","author":"Malbrain","year":"2012","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/bjs.1800820234","article-title":"Prospective study of intra-abdominal hypertension and renal function after laparotomy","volume":"82","author":"Sugrue","year":"1995","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2010121222","article-title":"Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome","volume":"22","author":"Mohmand","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1797.2006.00586.x","article-title":"Clinical characteristics of patients with segmental renal infarction","volume":"11","author":"Chu","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00005792-199911000-00004","article-title":"Acute renal infarction. Clinical characteristics of 17 patients","volume":"78","author":"Domanovits","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.ajkd.2015.09.019","article-title":"Clinical characteristics and outcomes of renal infarction","volume":"67","author":"Oh","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrneph.2010.71","article-title":"Drug-induced acute interstitial nephritis","volume":"6","author":"Perazella","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.ajkd.2012.06.030","article-title":"Abdominal compartment syndrome and acute kidney injury due to excessive auto-positive end-expiratory pressure","volume":"61","author":"Matthew","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib21","doi-asserted-by":"crossref","first-page":"e6006","DOI":"10.1097\/MD.0000000000006006","article-title":"How much does decompressive laparotomy reduce the mortality rate in primary abdominal compartment syndrome?: a single-center prospective study on 66 patients","volume":"96","author":"Muresan","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0039-6109(05)70585-5","article-title":"Abdominal compartment syndrome. The Nashville experience","volume":"77","author":"Eddy","year":"1997","journal-title":"Surg Clin North Am"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0741-5214(87)90144-3","article-title":"Acute renal artery occlusion: when is revascularization justified?","volume":"5","author":"Ouriel","year":"1987","journal-title":"J\u00a0Vasc Surg"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib24","first-page":"1","article-title":"Traumatic renal artery occlusion: a review of the literature","volume":"4","author":"Haas","year":"1998","journal-title":"Tech Urol"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib25","first-page":"557","article-title":"Traumatic renal artery occlusion: a 15-year review","volume":"45","author":"Haas","year":"1998","journal-title":"J\u00a0Trauma"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/01.hjh.0000239302.55754.1f","article-title":"Blood pressure and renal outcomes in patients with kidney infarction and hypertension","volume":"24","author":"Paris","year":"2006","journal-title":"J\u00a0Hypertens"},{"issue":"263","key":"10.1016\/j.ccc.2021.11.010_bib27","first-page":"221","article-title":"Renal biopsy in patients with unexplained renal impairment and normal kidney size","volume":"70","author":"Farrington","year":"1989","journal-title":"Q\u00a0J Med"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib30","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/ckj\/sfab107","article-title":"Acute tubulointerstitial nephritis and COVID-19","volume":"14","author":"Ng","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ccc.2021.11.010_bib31","doi-asserted-by":"crossref","first-page":"724728","DOI":"10.3389\/fped.2021.724728","article-title":"Case report: pediatric renal sarcoidosis and prognostic factors in reviewed cases","volume":"9","author":"Klaus","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ccc.2021.11.010_bib32","first-page":"101495","article-title":"Sarcoidosis beyond pulmonary involvement: a case series of unusual presentations","volume":"34","author":"Medhat","year":"2021","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.04660513","article-title":"The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease","volume":"9","author":"Ambruzs","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ophtha.2007.01.002","article-title":"Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome","volume":"114","author":"Mackensen","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib35","first-page":"587","article-title":"Familial chronic interstitial nephropathy with hyperuricaemia caused by the UMOD gene","volume":"33","author":"Ayasreh-Fierro","year":"2013","journal-title":"Nefrologia"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00467-011-1992-9","article-title":"Tubulointerstitial injury and the progression of chronic kidney disease","volume":"27","author":"Hodgkins","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.ccc.2021.11.010_bib38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2010.88","article-title":"An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease","volume":"77","author":"Garcia-Sanchez","year":"2010","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib39","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1681\/ASN.2010090941","article-title":"Adenovirus interstitial nephritis and rejection in an allograft","volume":"22","author":"Storsley","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib40","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ccc.2021.11.010_bib41","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2215\/CJN.07630717","article-title":"Drug-induced acute interstitial nephritis","volume":"12","author":"Moledina","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccc.2021.11.010_bib42","series-title":"Nephritic syndrome","author":"Hashmi","year":"2021"},{"key":"10.1016\/j.ccc.2021.11.010_bib43","series-title":"Rapidly progressive glomerulonephritis","author":"Naik","year":"2021"},{"issue":"930","key":"10.1016\/j.ccc.2021.11.010_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/pmj.79.930.206","article-title":"Acute glomerulonephritis","volume":"79","author":"Vinen","year":"2003","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1378\/chest.08-3043","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease","volume":"136","author":"Gomez-Puerta","year":"2009","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ccc.2021.11.010_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0961203308089693","article-title":"Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis","volume":"17","author":"Solans-Laque","year":"2008","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/md.0b013e318067da56","article-title":"Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases","volume":"86","author":"Lazor","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2005.08.007","article-title":"Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature","volume":"35","author":"Trapani","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1526-4637.2003.03001.x","article-title":"Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory","volume":"4","author":"Greco","year":"2003","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/08916930600886851","article-title":"Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies","volume":"39","author":"Lee","year":"2006","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/00007611-197710000-00015","article-title":"Acute glomerulonephritis in children: a review of 153 cases","volume":"70","author":"Sanjad","year":"1977","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1440-1754.2007.01109.x","article-title":"Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review","volume":"43","author":"Blyth","year":"2007","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-91-1-76","article-title":"Poststreptococcal acute glomerulonephritis: fact and controversy","volume":"91","author":"Nissenson","year":"1979","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib55","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00002281-199110000-00010","article-title":"Drug-related lupus","volume":"3","author":"Hess","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ccc.2021.11.010_bib56","series-title":"Gene Reviews\u00ae","first-page":"56","article-title":"C3 glomerulopathy","author":"Martin","year":"1993"},{"issue":"9","key":"10.1016\/j.ccc.2021.11.010_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11926-013-0369-4","article-title":"Genetics and epigenetics of systemic lupus erythematosus","volume":"15","author":"Costa-Reis","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"3 Suppl 82","key":"10.1016\/j.ccc.2021.11.010_bib58","first-page":"S90","article-title":"Genetics of ANCA-associated vasculitides: HLA and beyond","volume":"32","author":"Alberici","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000321324","article-title":"Advances in the genetics of anti-glomerular basement membrane disease","volume":"32","author":"Zhou","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ccc.2021.11.010_bib60","unstructured":"Rodriguez-Iturbe B, Haas M. Post-streptococcal glomerulonephritis. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: basic biology to clinical manifestations. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016."},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib61","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V641178","article-title":"Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome","volume":"6","author":"Kalluri","year":"1995","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00467-010-1554-6","article-title":"Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis","volume":"26","author":"Eison","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib63","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib64","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib65","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ccc.2021.11.010_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ccc.2021.11.010_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccc.2021.11.010_bib68","doi-asserted-by":"crossref","first-page":"6369814","DOI":"10.1155\/2018\/6369814","article-title":"Prognostic factors for survival and relapse in anca-associated vasculitis with renal involvement: a clinical long-term follow-up study","volume":"2018","author":"Salmela","year":"2018","journal-title":"Int J Nephrol"},{"issue":"17","key":"10.1016\/j.ccc.2021.11.010_bib69","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccc.2021.11.010_bib70","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"38\u201339","key":"10.1016\/j.ccc.2021.11.010_bib71","first-page":"905","article-title":"[Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia]","volume":"85","author":"Gasser","year":"1955","journal-title":"Schweiz Med Wochenschr"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib72","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2021.11.010_bib73","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0039-1694995","article-title":"Sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"46","author":"Iba","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MOH.0b013e32833cae86","article-title":"Atypical hemolytic uremic syndrome","volume":"17","author":"Kavanagh","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ccc.2021.11.010_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12959-020-00231-0","article-title":"Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in\u00a0vivo hemostasis and endothelial molecular pathogenesis","volume":"18","author":"Chang","year":"2020","journal-title":"Thromb J"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib78","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: a 5-year overview","volume":"5","author":"Toh","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib79","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","article-title":"Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy","volume":"16","author":"Wada","year":"2018","journal-title":"Thromb J"},{"issue":"10095","key":"10.1016\/j.ccc.2021.11.010_bib81","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcl.2018.09.011","article-title":"Hemolytic uremic syndrome","volume":"66","author":"Cody","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7050137","article-title":"Shiga-Toxin producing escherichia coli in Brazil: a systematic review","volume":"7","author":"Castro","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.ccc.2021.11.010_bib85","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib86","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.ccc.2021.11.010_bib87","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/ndt\/gft198","article-title":"The role of complement in streptococcus pneumoniae-associated haemolytic uraemic syndrome","volume":"28","author":"Szilagyi","year":"2013","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib88","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00431-005-0041-8","article-title":"Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan","volume":"165","author":"Huang","year":"2006","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib89","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1053\/ajkd.2001.21359","article-title":"Renal transplantation after streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"37","author":"Krysan","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12882-017-0512-y","article-title":"Case report - atypical hemolytic uremic syndrome triggered by influenza B","volume":"18","author":"Kobbe","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-010-1636-5","article-title":"Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection","volume":"26","author":"Trachtman","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib92","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10157-011-0516-z","article-title":"Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage","volume":"15","author":"Rhee","year":"2011","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF01703952","article-title":"Hemolytic-uremic syndrome associated with pancreatitis in an HIV-positive patient","volume":"65","author":"Cervero Marti","year":"1992","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2013.08.031","article-title":"Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency","volume":"63","author":"Cornec-Le Gall","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ped.12953","article-title":"Cobalamin C defect-hemolytic uremic syndrome caused by new mutation in MMACHC","volume":"58","author":"Adrovic","year":"2016","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib96","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2622","article-title":"DGKE and atypical HUS","volume":"45","author":"Quaggin","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib97","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.08520814","article-title":"Characterization of a New DGKE intronic mutation in genetically unsolved cases of familial atypical hemolytic uremic syndrome","volume":"10","author":"Mele","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib98","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjh.12907","article-title":"Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?","volume":"166","author":"Favre","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ccc.2021.11.010_bib100","first-page":"649","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Govind Babu","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ccc.2021.11.010_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2021.05.040","article-title":"Systemic autoimmune disorders associated with thrombotic microangiopathy: a cross-sectional analysis from the French National TMA registry: systemic autoimmune disease-associated TMA","volume":"93","author":"Martis","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib103","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"Hemolytic uremic syndrome; pathogenesis, treatment, and outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib104","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccc.2021.11.010_bib105","first-page":"5","article-title":"Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome","volume":"3","author":"Ohanian","year":"2011","journal-title":"Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J Nephrol"},{"key":"10.1016\/j.ccc.2021.11.010_bib107","series-title":"Public health reporting and national notification for Shiga toxin-producing Escherichia coli (STEC)","year":"2017"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib108","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/644621","article-title":"Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006","volume":"49","author":"Gould","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib109","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"9464","key":"10.1016\/j.ccc.2021.11.010_bib110","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ccc.2021.11.010_bib111","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2215\/CJN.08921209","article-title":"Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome","volume":"5","author":"Nathanson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ccc.2021.11.010_bib112","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS)","volume":"34","author":"Khalid","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.ccc.2021.11.010_bib113","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/toxins4111261","article-title":"Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals","volume":"4","author":"Mayer","year":"2012","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0016-5085(90)91241-W","article-title":"Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases","volume":"99","author":"Griffin","year":"1990","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib115","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.ccc.2021.11.010_bib116","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood-2011-06-363648","article-title":"Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib117","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MNH.0b013e328354a62e","article-title":"Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics","volume":"21","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib119","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib120","first-page":"441","article-title":"Hemolytic uremic syndrome in children","volume":"68","author":"Talarico","year":"2016","journal-title":"Minerva Pediatr"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib122","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpediatrics.2011.152","article-title":"Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome","volume":"165","author":"Hickey","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib123","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"26","key":"10.1016\/j.ccc.2021.11.010_bib124","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib125","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ccc.2021.11.010_bib126","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa1106482","article-title":"German outbreak of Escherichia coli O104:H4 associated with sprouts","volume":"365","author":"Buchholz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tmrv.2016.06.004","article-title":"Clinical and laboratory consequences of platelet transfusion in shiga toxin-mediated hemolytic uremic syndrome","volume":"31","author":"Beneke","year":"2017","journal-title":"Transfus Med Rev"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib128","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00467-013-2414-y","article-title":"Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome","volume":"28","author":"Balestracci","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ccc.2021.11.010_bib129","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1744-9987.12768","article-title":"Is plasma exchange efficacious in shiga toxin-associated hemolytic uremic syndrome? A Narrative Review of Current Evidence","volume":"23","author":"Keenswijk","year":"2019","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ccc.2021.11.010_bib131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/CLEP.S245642","article-title":"Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review","volume":"12","author":"Yan","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.ccc.2021.11.010_bib132","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib133","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12882-016-0420-6","article-title":"Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients","volume":"18","author":"Besbas","year":"2017","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib134","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.kint.2017.04.028","article-title":"Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland","volume":"92","author":"Brocklebank","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib136","doi-asserted-by":"crossref","first-page":"e1764","DOI":"10.1542\/peds.2013-1594","article-title":"Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome","volume":"133","author":"Diamante Chiodini","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib137","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00467-013-2416-9","article-title":"Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab","volume":"28","author":"Gulleroglu","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib138","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00277-012-1615-y","article-title":"Profound neurological injury in a patient with atypical hemolytic uremic syndrome","volume":"92","author":"Salem","year":"2013","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib139","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome","volume":"34","author":"Formeck","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.RV17026","article-title":"Pathogenesis of atypical hemolytic uremic syndrome","volume":"26","author":"Yoshida","year":"2019","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib141","first-page":"400","article-title":"The genetics of atypical hemolytic uremic syndrome","volume":"30","author":"Feitz","year":"2018","journal-title":"Med Genet"},{"key":"10.1016\/j.ccc.2021.11.010_bib142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldl004","article-title":"Atypical haemolytic uraemic syndrome","volume":"77-78","author":"Kavanagh","year":"2006","journal-title":"Br Med Bull"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib143","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib144","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib145","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome","volume":"152","author":"Azoulay","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ccc.2021.11.010_bib146","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fmed.2020.00212","article-title":"An update in drug-induced thrombotic microangiopathy","volume":"7","author":"Chatzikonstantinou","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ccc.2021.11.010_bib147","series-title":"GeneReviews\u00ae","article-title":"Genetic atypical hemolytic-uremic syndrome","author":"Noris","year":"1993"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib148","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"23","key":"10.1016\/j.ccc.2021.11.010_bib149","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib151","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib152","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"10.1016\/j.ccc.2021.11.010_bib153","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","article-title":"How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.NURSE.0000549721.69197.4d","article-title":"Acquired autoimmune thrombotic thrombocytopenic purpura","volume":"49","author":"Vacca","year":"2019","journal-title":"Nursing"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib155","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib156","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib157","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.ccc.2021.11.010_bib159","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib160","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/S2352-3026(17)30024-8","article-title":"The PLASMIC score for thrombotic thrombocytopenic purpura","volume":"4","author":"Jamme","year":"2017","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.ccc.2021.11.010_bib161","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/trf.15954","article-title":"Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Paydary","year":"2020","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib162","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.ccc.2021.11.010_bib163","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood.2020006052","article-title":"Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura","volume":"137","author":"Goshua","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib164","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.ccc.2021.11.010_bib165","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2014-10-559211","article-title":"The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura","volume":"125","author":"Lim","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ccc.2021.11.010_bib166","first-page":"829","article-title":"HELLP syndrome: recognition and perinatal management","volume":"60","author":"Padden","year":"1999","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.ccc.2021.11.010_bib167","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 Pt 1","key":"10.1016\/j.ccc.2021.11.010_bib168","first-page":"662","article-title":"The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy","volume":"91","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.ccc.2021.11.010_bib169","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ccc.2021.11.010_bib170","first-page":"1","article-title":"Edema associated with low plasma protein level and any gestational hypertension as warning signs of HELLP syndrome","author":"Carbillon","year":"2021","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib171","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ccc.2021.11.010_bib172","first-page":"910751","article-title":"Genetic aspects of preeclampsia and the HELLP syndrome","volume":"2014","author":"Haram","year":"2014","journal-title":"J\u00a0Pregnancy"},{"key":"10.1016\/j.ccc.2021.11.010_bib173","first-page":"87","article-title":"Chapter four - matrix metalloproteinases in normal pregnancy and preeclampsia","volume":"Vol 148","author":"Chen","year":"2017"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib174","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2021.11.010_bib175","first-page":"309","article-title":"Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia","volume":"64","author":"Lamarca","year":"2012","journal-title":"Minerva Ginecol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib176","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"issue":"11","key":"10.1016\/j.ccc.2021.11.010_bib177","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3109\/14767058.2012.694923","article-title":"The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome","volume":"25","author":"Crovetto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ccc.2021.11.010_bib178","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2020.08.038","article-title":"Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome","volume":"196","author":"Bazzan","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib179","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2021.11.010_bib180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/asheducation-2017.1.144","article-title":"Thrombocytopenia in pregnancy","volume":"2017","author":"Cines","year":"2017","journal-title":"Hematoly Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib181","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2018.38.2.95","article-title":"Evaluation of sFlt-1\/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center","volume":"38","author":"Caillon","year":"2018","journal-title":"Ann Lab Med"},{"issue":"2","key":"10.1016\/j.ccc.2021.11.010_bib182","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"issue":"5 Pt 1","key":"10.1016\/j.ccc.2021.11.010_bib183","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ccc.2021.11.010_bib184","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of obstetricians and gynecologists\u2019 task force on hypertension in pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ccc.2021.11.010_bib185","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0002-9378(96)70216-8","article-title":"Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count)","volume":"174","author":"Barton","year":"1996","journal-title":"Am J Obstet Gynecol"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070421000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070421000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:20:20Z","timestamp":1760062820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070421000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":185,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0749070421000968"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2021.11.010","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncommon Causes of Acute Kidney Injury","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2021.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}